-

 

Fish Oil And Prostate Cancer 







A year-long diet high in omega-3s and low in omega-6s, paired with fish oil supplements, may help slow down prostate cancer progression in men who are monitoring their cancer through active surveillance, according to new research published online Dec. 13 in the Journal of Clinical Oncology.

Researchers led by Dr. William J. Aronson at UCLA tracked 100 men with early-stage prostate cancer (grade 1 or 2) who chose active surveillance instead of immediate treatment. The study compared those who followed the special diet and took fish oil capsules (dubbed D + FO) to a control group.

After one year, the D + FO group saw their Ki-67 index—a marker linked to cancer cell growth—drop by about 15% (from 1.34% to 1.14%). In contrast, the control group’s Ki-67 index rose by roughly 24% (from 1.23% to 1.52%). This difference was statistically significant. When it came to other measures like cancer grade, tumor size, Decipher genomic risk score, and PSA levels, there wasn’t much difference between the two groups. Four men in the D + FO group left the study because of side effects from the fish oil.

The authors say these results pave the way for larger phase III trials to see if this diet and supplement combo could benefit more men choosing surveillance over immediate prostate cancer treatment.

It’s worth noting that two authors reported connections to the pharmaceutical industry.

A quick reminder: Statistics from medical studies show general patterns and might not apply to everyone. For decisions about your own health, always talk to your doctor.


Comments

Post a Comment

Popular posts from this blog

-
Image
DIABETES: PREVENTION, MANAGEMENT, AND TREATMENT   Diabetes is a complex, chronic condition that comes in several forms, each with its own causes, risks, and best ways to manage it.  Diabetes alters how your body uses insulin, a hormone produced in the pancreas that helps cells absorb sugar and store it as glycogen. When glycogen is unavailable to your cells, they lack an energy source. The two most common types of Diabetes are Type 1 and Type 2 diabetes. Type 1 is primarily an autoimmune issue—your own immune system mistakenly destroys the insulin-producing cells in your pancreas (Nature Reviews Disease Primers) There are also rare, less-understood forms, often linked to genetics. Type 2 diabetes, which accounts for over 90% of all cases, develops when your body becomes resistant to insulin or doesn't make enough of it (Nature Reviews Disease Primers; NY.gov). Symptoms can be similar to those of Type 1, but often develop more gradually and may also include blurred vision, slow...
Read more
-
Image
COLONOSCOPY: WHAT YOU NEED TO KNOW A colonoscopy remains one of the most effective ways to detect and prevent colorectal cancer before it becomes a serious threat. During the procedure, doctors can find and remove precancerous polyps, significantly lowering your chances of developing colorectal cancer later on. Studies consistently show that getting a colonoscopy every 10 years—recommended for most adults at average risk—both saves lives and costs less over time than other screening methods, such as yearly fecal occult blood tests (FOBTs) (Annals of Internal Medicine). Medical experts generally recommend starting regular colonoscopy screenings around age 45 or 50, depending on your health history, and repeating them every 10 years if no issues are found. This timeline is supported by substantial evidence showing that colorectal cancer rates remain very low within 10 years of a clean colonoscopy (BMJ). If colorectal cancer or certain polyps run in your family, your doctor might suggest ...
Read more

Diabetes drugs may reduce the risk of Alzheimer’s.

-
Image
    Diabetes drugs may reduce the risk of Alzheimer’s. The study finds people taking the drugs have fewer biomarkers, slower cognitive decline. People taking certain drugs to lower blood sugar for type 2 diabetes had less amyloid in the brain, a biomarker of Alzheimer's disease compared to people with type 2 diabetes who are not taking the drugs and those without diabetes. The new study, published in the August 11, 2021, online issue of  Neurology , the medical journal of the American Academy of Neurology, also found people taking these drugs, called dipeptidyl peptidase-4 inhibitors, showed slower cognitive decline than people in the other two groups. In people with type 2 diabetes, the body no longer efficiently uses insulin to control blood sugar. Dipeptidyl peptidase-4 inhibitors, also known as gliptins, can be prescribed when other diabetes drugs do not work. They help control blood sugar when combined with diet and exercise. "People with diabetes have been shown to ...
Read more